134 related articles for article (PubMed ID: 1763501)
1. Can anti-HBc testing decrease the residual risk of transfusion-related HIV transmission?
Fiedler H
Vox Sang; 1991; 61(2):144-5. PubMed ID: 1763501
[No Abstract] [Full Text] [Related]
2. Prevention of transmission of hepatitis B, hepatitis C and human immunodeficiency virus infections through blood transfusion by anti-HBc testing.
Busch MP
Vox Sang; 1998; 74 Suppl 2():147-54. PubMed ID: 9704438
[No Abstract] [Full Text] [Related]
3. [Antibodies against hepatitis B virus core antigen among blood donors].
Moncharmont P; Bourgeot C; Papon S; Duraffourg M
Transfus Clin Biol; 2000 Feb; 7(1):63-9. PubMed ID: 10730347
[TBL] [Abstract][Full Text] [Related]
4. Isolated anti-HBc-IgM antibody among blood donors in the semi-arid region of Nigeria.
Jeremiah ZA; Idris H; Ajayi BB; Ezimah AC; Malah MB; Baba MM
Hum Antibodies; 2011; 20(3-4):77-82. PubMed ID: 22129677
[TBL] [Abstract][Full Text] [Related]
5. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.
Katz L; Strong DM; Tegtmeier G; Stramer S
Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367
[TBL] [Abstract][Full Text] [Related]
6. Anti-HBc testing can decrease the residual risk of transfusion-related HIV transmission by more than one third.
Le Pont F; Massari V; Jullien AM; Costagliola D; Valleron AJ
Vox Sang; 1990; 59(4):248-50. PubMed ID: 2293465
[No Abstract] [Full Text] [Related]
7. Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: Implications for blood transfusion.
Asim M; Ali R; Khan LA; Husain SA; Singla R; Kar P
Indian J Med Res; 2010 Sep; 132():312-7. PubMed ID: 20847378
[TBL] [Abstract][Full Text] [Related]
8. [Anti-HB-core antibodies as a surrogate marker in blood donors].
Blejer JL; Saguier MC; Salamone HJ
Sangre (Barc); 1999 Jun; 44(3):240-1. PubMed ID: 10481590
[No Abstract] [Full Text] [Related]
9. Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection.
Bhattacharya P; Chandra PK; Datta S; Banerjee A; Chakraborty S; Rajendran K; Basu SK; Bhattacharya SK; Chakravarty R
World J Gastroenterol; 2007 Jul; 13(27):3730-3. PubMed ID: 17659734
[TBL] [Abstract][Full Text] [Related]
10. Occult hepatitis B infection and transfusion-transmission risk.
Candotti D; Boizeau L; Laperche S
Transfus Clin Biol; 2017 Sep; 24(3):189-195. PubMed ID: 28673499
[TBL] [Abstract][Full Text] [Related]
11. Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening.
Kleinman SH; Kuhns MC; Todd DS; Glynn SA; McNamara A; DiMarco A; Busch MP;
Transfusion; 2003 Jun; 43(6):696-704. PubMed ID: 12757519
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of "anti-HBc alone" among Syrian blood donors.
Muselmani W; Habbal W; Monem F
J Infect Dev Ctries; 2014 Aug; 8(8):1013-5. PubMed ID: 25116667
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of antibodies to hepatitis B core antigen and occult hepatitis B virus infections in Korean blood donors.
Seo DH; Whang DH; Song EY; Kim HS; Park Q
Transfusion; 2011 Aug; 51(8):1840-6. PubMed ID: 21332731
[TBL] [Abstract][Full Text] [Related]
14. The yield of universal antibody to hepatitis B core antigen donor screening in the Netherlands, a hepatitis B virus low-endemic country.
van de Laar TJ; Marijt-van der Kreek T; Molenaar-de Backer MW; Hogema BM; Zaaijer HL
Transfusion; 2015 Jun; 55(6):1206-13. PubMed ID: 25494685
[TBL] [Abstract][Full Text] [Related]
15. Significance of screening antibodies to hepatitis B virus core antigen among Syrian blood donors.
Muselmani W; Habbal W; Monem F
Transfus Med; 2013 Aug; 23(4):265-8. PubMed ID: 23621787
[TBL] [Abstract][Full Text] [Related]
16. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
[TBL] [Abstract][Full Text] [Related]
17. [HIV seropositivity in blood donations: prevalence, residual risk and epidemiology. The "Retrovirus" Work Group of the French Society of Blood Transfusion].
Couroucé AM
Transfus Clin Biol; 1995; 2(5):357-63. PubMed ID: 8581178
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus screening in contacts of blood donors with antibodies against core protein (anti-HBC), but without surface antigen (HBsAg).
Fortes HM; Ribeiro LC; Perazolo GF; Souto FJ
Mem Inst Oswaldo Cruz; 2006 Mar; 101(2):195-9. PubMed ID: 16830712
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of algorithms for the diagnostic assessment and the reentry of blood donors who tested reactive for antibodies against hepatitis B core antigen.
Juhl D; Luhm J; Görg S; Ziemann M; Hennig H
Transfusion; 2011 Jul; 51(7):1477-85. PubMed ID: 21276000
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity and specificity of Anti-HBc screening assays--which assay is best for blood donor screening?
Hourfar MK; Walch LA; Geusendam G; Dengler T; Janetzko K; Gubbe K; Frank K; Karl A; Löhr M; Sireis W; Seifried E; Schmidt M
Int J Lab Hematol; 2009 Dec; 31(6):649-56. PubMed ID: 18673399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
